Fosamax Linked to Rare Jaw Disorder
Fosamax is a widely prescribed drug to treat osteoperosis. The drug is included in a class of drugs called bisphosphonates, which work by inhibiting the bone function which removes old bone so that new bone may be laid.
The drug, as reported in the Journal of Oral and Maxillofacial Surgeons, is linked to a rare and serious jaw bone disorder called Osteonecrosis of the Jaw or "ONJ". Individuals who have dental work while on the drug are especially at risk.
Fosamax, manufactured by Merck, had sales of over $1 billion dollars last year alone.
Read more here.
Post A Comment / Question